Tue, May 31, 2022
Mon, May 30, 2022
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022

Charles Duncan Maintained (STOK) at Buy with Decreased Target to $38 on, May 26th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-38-on-may-26th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Duncan of Cantor Fitzgerald, Maintained "Stoke Therapeutics, Inc." (STOK) at Buy with Decreased Target from $68 to $38 on, May 26th, 2022.

Charles has made no other calls on STOK in the last 4 months.



There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Charles's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Charles


  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $40 on, Wednesday, March 16th, 2022
  • Suji Jeong of "Jefferies" Initiated at Strong Buy and Held Target at $50 on, Monday, January 31st, 2022

Publication Contributing Sources